Business Context and Reporting Period
Company: InMed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 4, 2021
Reporting Period: Single event date (May 4, 2021)
Business Context: The filing serves as a Regulation FD disclosure to announce an upcoming presentation by the company's President and CEO at an industry conference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely discloses a scheduled corporate presentation.
Guidance, Outlook, and Management Commentary
- Event Announcement: Eric A. Adams, President and CEO, is scheduled to present at Canaccord Genuity's 5th Annual Global Cannabis Conference on Tuesday, May 11, 2021.
- Legal Disclaimer: The information provided, including the news release (Exhibit 99.1), is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the Canaccord Genuity 5th Annual Global Cannabis Conference presentation.
- Review the full text of the news release (Exhibit 99.1) referenced in the filing for specific details on the presentation content.
- Confirm the company's status as an emerging growth company (indicated as "Yes" in the filing).